|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/59 | (2006.01) |
| A61P 5/20 | (2006.01) |
| (11) | Number of the document | 2679228 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13177274.1 |
| Date of filing the European patent application | 2007-06-21 | |
| (97) | Date of publication of the European application | 2014-01-01 |
| (45) | Date of publication and mention of the grant of the patent | 2018-03-21 |
| (46) | Date of publication of the claims translation | 2018-05-10 |
| (30) | Number | Date | Country code |
| 815148 P | 2006-06-21 | US |
| (72) |
Bishop, Charles W., US
Crawford, Keith H., US
Messner, Eric J., US
Petkovich, P. Martin, CA
Helvig, Christian F., CA
|
| (73) |
Opko Ireland Global Holdings, Ltd.,
Citywest Business Campus 3013 Lake Drive, Dublin 24,
IE
Opko Renal, LLC, 4400 Biscayne Boulevard, Miami, FL 33137, US |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Terapija naudojant vitamino D atstatymo agentą ir vitamino D hormoninį pakaitinį agentą |
| Therapy using vitamin D repletion agent and vitamin D hormone replacement agent |
| Payment date | Validity (years) | Amount | |
| 2024-06-03 | 18 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2025-06-21 |